Indiplon-IR: NBIX started a double-blind, placebo-controlled North American Phase III study of indiplon-IR in 360 patients to treat chronic insomnia in elderly

Neurocrine Biosciences Inc. (NBIX), San Diego, Calif.
Product: Indiplon-IR ( NBI-34060-IR)
Business: Neurological
Therapeutic

Read the full 141 word article

How to gain access

Continue reading with a
two-week free trial.